Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

1d ago, source: Finanznachrichten

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported ...

ATXS Astria Therapeutics, Inc.

17d ago, source: Seeking Alpha

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting

2d ago, source:

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present ...

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors

1mon ago, source: Nasdaq

BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today ...

Astria Therapeutics Stock (NASDAQ:ATXS), Analyst Ratings, Price Targets, Predictions

5mon ago, source: Benzinga.com

Astria Therapeutics Inc has a consensus price target of $21.6, established from looking at the 20 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Wedbush ...

Buy Recommendation for Astria Therapeutics Backed by Promising ALPHA-STAR Trial Results

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. Astria Therapeutics (ATXS) Company Description: Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel ...

Buy Rating Affirmed for Astria Therapeutics on Promising STAR-0215 Data and Market Potential

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. Astria Therapeutics (ATXS) Company Description: Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel ...

Astria Therapeutics, Inc. (ATXS)

24d ago, source: Yahoo Finance

BOSTON, May 02, 2024--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock ...

Astria Therapeutics, Inc.

4mon ago, source: CNN

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary ...

Astria Therapeutics Inc ATXS

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Astria Therapeutics Inc.

25d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...